A new patented scientific discovery by the INR, as documented in the videos below, now promises to change current thinking about the potential for recovery after stroke or brain injury, even years later.
SCROLL DOWN TO VIEW VIDEOS
60 Minutes Australia “Reverse Stroke” 23 min. version
Copyright 2017 60 Minutes Australia and INR PLLC, all rights reserved
Improvement in Post-Stroke Pain, Gait, & Vision: from Cameroon to the INR in Boca Raton, July 2017
From Cameroon, Africa, improvements in gait, vision, post-stroke pain, hand function, and sensation starting within minutes after treatment at the INR Boca Raton, 22 months after stroke.
See her phone follow-up video here: https://youtu.be/rluAvqFYHCM
Physician discusses rapid improvement ten years after stroke at the INR
Rapid improvement in chronic central post-stroke pain and motor function 3 years after stroke in a patient from England
Treatment at the INR PLLC in Boca Raton, Florida, in February 2012. Rapid improvement in chronic post-stroke pain, fine motor function of the left hand, and other neurological improvements documented.
Vision, Hand Function, Chronic Post-Stroke Pain, Range of Motion, Sensation & Gait Improvements 5 Years After Stroke
Patient and wife discuss improvements in vision, hand function, chronic post-stroke pain, range of motion, sensation, and gait five years after stroke with treatment at the INR PLLC in Boca Raton, Florida.
Immediate improvement in gait and post-stroke aphasia in a patient from Vermont 2 years after stroke in July 2015
Immediate improvement in chronic post-stroke aphasia (naming of family members) and restoration of the ability to run within minutes of treatment at the INR PLLC in Boca Raton, Florida, in July 2015, two years after his stroke. The patient was accompanied by his wife and children, who comment on his rapid and remarkable therapeutic response.
Exemplary Literature Reference:
- Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, Depuy V. Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with PSE. CNS Drugs. 2012;26(12):1051-70.